July 2, 2022
PARIS (Reuters) – French drugmaker Sanofi’s forecast for a return to profit growth after three years of decline failed to impress investors on Thursday, sending its shares to a one-year low.
Your email address will not be published.
Save my name, email, and website in this browser for the next time I comment.